Keywords: big, pharma, continuing, dominate, top-selling, drugs, market
Big pharma continuing to dominate top-selling drugs market, says IMS
Article | 18 October 2001
The only $1 billion-selling drug product to be made by a company outsidethe world's top 20 corporations is Mundi International's painkiller OxyContin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
